Gastroenterology :: FDA reviewing Entereg, Alvimopan for POI – postoperative ileus
GlaxoSmithKline and Adolor Corporation announced that the US Food and Drug Administration (FDA) has accepted as complete, Adolor?s response to the November 2006 New Drug Application (NDA) approvable letter for Entereg? (alvimopan) for the management of postoperative ileus (POI).